Insider · CIK 0002021595
Mathi Gurusamy
officer
Files at LTRX (LANTRONIX INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Common Stock | +3,334 | $0.00 | $0 | 84,140 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Common Stock | +7,975 | $0.00 | $0 | 92,115 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Common Stock | +7,118 | $0.00 | $0 | 99,233 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | FTax withholding Common Stock | -8,452 | $5.15 | $44k | 90,781 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Common Stock | +15,335 | $0.00 | $0 | 106,116 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | FTax withholding Common Stock | -7,035 | $5.15 | $36k | 99,081 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -3,334 | $0.00 | $0 | 10,004 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -7,975 | $0.00 | $0 | 23,924 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -7,118 | $0.00 | $0 | 49,825 | 39 d ago |
| Sep 1, 2026 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -15,335 | $0.00 | $0 | 21,469 | 39 d ago |
| Dec 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +3,334 | $0.00 | $0 | 59,453 | Dec 3, 2025 |
| Dec 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +7,975 | $0.00 | $0 | 67,428 | Dec 3, 2025 |
| Dec 1, 2025 | LTRX LANTRONIX INC | FTax withholding Common Stock | -4,045 | $5.21 | $21k | 63,383 | Dec 3, 2025 |
| Dec 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -3,335 | $0.00 | $0 | 20,007 | Dec 3, 2025 |
| Dec 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -7,975 | $0.00 | $0 | 47,848 | Dec 3, 2025 |
| Sep 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +3,335 | $0.00 | $0 | 52,190 | Sep 3, 2025 |
| Sep 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +7,975 | $0.00 | $0 | 60,165 | Sep 3, 2025 |
| Sep 1, 2025 | LTRX LANTRONIX INC | FTax withholding Common Stock | -4,046 | $4.97 | $20k | 56,119 | Sep 3, 2025 |
| Sep 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -3,335 | $0.00 | $0 | 23,341 | Sep 3, 2025 |
| Sep 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -7,975 | $0.00 | $0 | 55,823 | Sep 3, 2025 |
| Jul 11, 2025 | LTRX LANTRONIX INC | AGrant or award Restricted Stock Unitsderivative | +84,989 | $0.00 | $0 | 84,989 | Jul 15, 2025 |
| Jul 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +13,335 | $0.00 | $0 | 53,626 | Jul 2, 2025 |
| Jul 1, 2025 | LTRX LANTRONIX INC | FTax withholding Common Stock | -4,771 | $2.82 | $13k | 48,855 | Jul 2, 2025 |
| Jul 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -13,335 | $0.00 | $0 | 26,676 | Jul 2, 2025 |
| Jun 1, 2025 | LTRX LANTRONIX INC | MOption exercise Common Stock | +31,893 | $0.00 | $0 | 52,443 | Jun 3, 2025 |
| Jun 1, 2025 | LTRX LANTRONIX INC | FTax withholding Common Stock | -12,152 | $2.19 | $27k | 40,291 | Jun 3, 2025 |
| Jun 1, 2025 | LTRX LANTRONIX INC | MOption exercise Restricted Stock Unitsderivative | -31,893 | $0.00 | $0 | 63,798 | Jun 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.